Mechanisms of selective copper removal by tetrathiomolybdate from metallothionein in LEC rats

被引:30
作者
Ogra, Y
Ohmichi, M
Suzuki, KT
机构
[1] CHIBA UNIV, FAC PHARMACEUT SCI, CHIBA 263, JAPAN
[2] CHIBA CITY INST HLTH & ENVIRONM, SAIWAI, CHIBA 261, JAPAN
关键词
tetrathiomolybdate; LEC rat; metallothionein; copper; Wilson disease; chelation therapy; HPLC/ICP-MS;
D O I
10.1016/0300-483X(95)03171-B
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Copper (Cu) was selectively removed from metallothionein (MT) in the liver of LEC rats (Long-Evans rats with a cinnamon-like coat color) in vivo and in vitro by tetrathiomolybdate (TTM). Female LEC rats were injected intraperitoneally with TTM at a dose of 10 mg/kg body weight for 8 consecutive days. More than 2/3 of the Cu accumulating in the liver was removed by TTM treatment 24 h after the last injection. Although most Cu was bound to MT in the soluble fraction before TTM treatment, the Cu remaining in the liver was present almost exclusively in the nonsoluble fraction together with molybdenum (Mo). Cu,Zn,Cd-MT was separated from the liver of LEC rats that had been injected with cadmium (Cd) and reacted with TTM at mol ratios of 0, 0.25, 0.50, 1.0, 2.0 and 4.0 to Cu bound to MT for 10 min at 37 degrees C. When TTM was added at a mol ratio of less than 1.0, a Cu,Zn,Cd-MT/TTM complex was detected, while addition of TTM at a mol ratio of greater than 1.0 selectively removed Cu from MT and produced a Cu/TTM complex via liberation of Zn,Cd-MT from the Cu,Zn,Cd-MT/TTM complex. Excessive TTM appeared to facilitate polymerization of the Cu/TTM complex to insoluble polymers. The dose-related formation of differing MT/TTM complexes explains the findings observed in vivo.
引用
收藏
页码:75 / 83
页数:9
相关论文
共 36 条
[1]   EFFECT OF MOLYBDENUM TREATMENTS ON THE DISTRIBUTION OF CU AND METALLOTHIONEIN IN TISSUE-EXTRACTS FROM RATS AND SHEEP [J].
ALLEN, JD ;
GAWTHORNE, JM .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1987, 31 (03) :161-170
[2]   COPPER-METABOLISM IN RATS GIVEN DITHIOMOLYBDATES OR TRITHIOMOLYBDATES [J].
BREMNER, I ;
MILLS, CF ;
YOUNG, BW .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1982, 16 (02) :109-119
[3]   INITIAL THERAPY OF PATIENTS WITH WILSONS-DISEASE WITH TETRATHIOMOLYBDATE [J].
BREWER, GJ ;
DICK, RD ;
YUZBASIYANGURKIN, V ;
TANKANOW, R ;
YOUNG, AB ;
KLUIN, KJ .
ARCHIVES OF NEUROLOGY, 1991, 48 (01) :42-47
[4]  
BREWER GJ, 1993, J AM COLL NUTR, V12, P26
[5]   THE WILSON DISEASE GENE IS A PUTATIVE COPPER TRANSPORTING P-TYPE ATPASE SIMILAR TO THE MENKES GENE [J].
BULL, PC ;
THOMAS, GR ;
ROMMENS, JM ;
FORBES, JR ;
COX, DW .
NATURE GENETICS, 1993, 5 (04) :327-337
[6]   THIOMOLYBDATES AND COPPER-MOLYBDENUM-SULFUR INTERACTION IN RUMINANT NUTRITION [J].
DICK, AT ;
DEWEY, DW ;
GAWTHORNE, JM .
JOURNAL OF AGRICULTURAL SCIENCE, 1975, 85 (DEC) :567-568
[7]  
Friedman L S, 1993, Gastroenterology, V104, P1566
[8]   LIVER COPPER CONCENTRATION IN WILSONS-DISEASE - EFFECT OF TREATMENT WITH ANTICOPPER AGENTS [J].
GIBBS, K ;
WALSHE, JM .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1990, 5 (04) :420-424
[9]   AN INVESTIGATION OF THE EFFECTS OF INTRAVENOUS ADMINISTRATION OF THIOMOLYBDATE ON COPPER-METABOLISM IN CHRONIC CU-POISONED SHEEP [J].
GOONERATNE, SR ;
HOWELL, JM ;
GAWTHORNE, JM .
BRITISH JOURNAL OF NUTRITION, 1981, 46 (03) :469-480
[10]  
Howell J. M., 1987, Copper in animals and man. Volume 2., P53